Paul Wedel, Former CEO of Lancaster General Hospital, Dies At 87

By Admin
Share
Paul G. Wedel, 87, who served as president and CEO of Lancaster General Hospital for 28 years was announced dead on Sunday, July 6. A cause of death wa...

Paul G. Wedel, 87, who served as president and CEO of Lancaster General Hospital for 28 years was announced dead on Sunday, July 6.

A cause of death was not released.

A leading force behind construction of the hospital’s Suburban Outpatient Pavilion, Wedel pioneered Lancaster’s growth from 1964 until 1992. It was reported that during one of his final visits with CFO and treasurer at Lancaster, F. Joseph Byorick, Wedel was still inquiring about the hospital.

Wedel oversaw various impactful moments during his time at Lancaster, including the first open-heart surgery in 1983, the induction of a new building adjacent to the School of Nursing in 1967, and the installment of the Family Medicine Residency Program in 1970. But he is best known for Lancaster General’s Suburban Outpatient Pavilion, which opened towards the end of his tenure. The pavilion has made it possible for individuals to receive outpatient care in a convenient and successful manner.

Surviving Wedel are his wife, Jean Martin of Lititz, and their four children, Dana of Berkely, California; Laurie of Lancaster; Paul John of Los Angeles; and Kurt of San Francisco. 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma